BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 7587886)

  • 21. [Renal failure and cystic kidney diseases].
    Correas JM; Joly D; Chauveau D; Richard S; Hélénon O
    J Radiol; 2011 Apr; 92(4):308-22. PubMed ID: 21549887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal polycystosis in pediatrics].
    Khoory BJ; Fanos V
    Pediatr Med Chir; 1998; 20(4):269-73. PubMed ID: 9866850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD; Ruthazer R; Terrin NC
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic kidney disease.
    Bergmann C; Guay-Woodford LM; Harris PC; Horie S; Peters DJM; Torres VE
    Nat Rev Dis Primers; 2018 Dec; 4(1):50. PubMed ID: 30523303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    McCarthy S; McMullen M
    ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal dominant polycystic kidney disease.
    Srivastava A; Patel N
    Am Fam Physician; 2014 Sep; 90(5):303-7. PubMed ID: 25251090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study.
    Tutal O; Gulhan B; Atayar E; Yuksel S; Ozcakar ZB; Soylemezoglu O; Saygili S; Caliskan S; Inozu M; Baskin E; Duzova A; Hayran M; Topaloglu R; Ozaltin F
    Nephron; 2024; 148(5):319-332. PubMed ID: 36657418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR-γ agonists in polycystic kidney disease with frequent development of cardiovascular disorders.
    Nagao S; Yamaguchi T
    Curr Mol Pharmacol; 2012 Jun; 5(2):292-300. PubMed ID: 22122459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the molecular diagnosis of polycystic kidney disease.
    Bergmann C
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1037-1054. PubMed ID: 28952822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models for human polycystic kidney disease.
    Nagao S; Kugita M; Yoshihara D; Yamaguchi T
    Exp Anim; 2012; 61(5):477-88. PubMed ID: 23095811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.
    Vijayakumar S; Dang S; Marinkovich MP; Lazarova Z; Yoder B; Torres VE; Wallace DP
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F640-54. PubMed ID: 24370592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cystic kidneys (autosomal dominant polycystic kidney disease)].
    Zeier M; Geberth S
    Ther Umsch; 1994 Dec; 51(12):801-6. PubMed ID: 7784992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease.
    Zhang Y; Reif G; Wallace DP
    Cell Signal; 2020 Aug; 72():109646. PubMed ID: 32311505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and Severe Polycystic Kidney Disease and Related Ciliopathies: An Emerging Field of Interest.
    Bergmann C
    Nephron; 2019; 141(1):50-60. PubMed ID: 30359986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative activity of cyst epithelium in human renal cystic diseases.
    Nadasdy T; Laszik Z; Lajoie G; Blick KE; Wheeler DE; Silva FG
    J Am Soc Nephrol; 1995 Jan; 5(7):1462-8. PubMed ID: 7703384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.
    Sweeney WE; Avner ED
    Pediatr Res; 2014 Jan; 75(1-2):148-57. PubMed ID: 24336431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abdominal sonographic study of autosomal dominant polycystic kidney disease.
    Nicolau C; Torra R; Bianchi L; Vilana R; Gilabert R; Darnell A; Brú C
    J Clin Ultrasound; 2000; 28(6):277-82. PubMed ID: 10867665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases.
    Goilav B; Satlin LM; Wilson PD
    Pediatr Nephrol; 2008 Sep; 23(9):1473-82. PubMed ID: 18516626
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.